DIH Receives Notice of Additional Basis for Delisting from The Nasdaq Stock Market DIH Has Requested Hearing to Appeal before Nasdaq Hearing Panel NORWELL, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) received a notice on September 12, 2025, from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the “Bid Price Rule”) and, accordingly, th ...

In this article, we will take a look at some of the best options for a dividend stock portfolio.Dividends have long been a magnet for investors. A Wall Street Journal report noted that many shareholders said they didn’t rely on dividend income right now but believed dividend-paying stocks tend to offer stronger returns with lower volatility.History backs up that view. Research from Ned Davis covering the past 50 years shows that S&P 500 companies paying dividends delivered annualized returns of 9.2%, more t ...

Healthcare payment concept with stethoscope and big money US dollar.gettyMost Wall Street “suits” are allergic to dividend cuts. These spreadsheet jockeys sooooo lack imagination. They prefer linear trends—up and to the right.Dividend growers model nicely. Payout “resets” (cuts!) do not. So, there is often a knee-jerk reaction from analysts to sell every divvie slash they see.Same goes for most individual income investors. These vanilla beans sold BlackRock Health Sciences Term Trust (BMEZ) late last week w ...

NEW YORK and NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into iRhythm Technologies, Inc. (NasdaqGS: IRTC). On May 30, 2023, the Company disclosed the receipt of a Warning Letter from the FDA regarding “non-conformities to regulations for medical devices, including medical device reporting requirements, relating to the Company’s Zio ...

分析师评级与目标价 - Needham维持波士顿科学公司买入评级 目标股价121美元 [1] - 评级基于公司计划在2025年底推出用于外周血管的Bolt激光血管内碎石系统 [1] 新产品与技术优势 - Bolt系统相比Shockwave Medical的IVL系统具有更好的输送性 更多脉冲和更可靠的目标声波治疗 [3] - 公司已开始进行骨折研究以评估IVL技术的临床应用 [2] - 外周介入和介入心脏病学产品组合及销售团队将助力快速获取IVL市场份额 [3] 市场机会与财务影响 - IVL市场存在85亿美元的市场机会 [2] - IVL技术预计在未来五年为收入增长贡献0.3% 为每股收益增长贡献0.5% [3] 公司背景 - 波士顿科学是全球医疗技术公司 专注于开发销售微创医疗设备以改善患者治疗效果并降低医疗成本 [4]

分析师评级与价格目标 - Bernstein SocGen Group重申对Intuitive Surgical的“跑赢大盘”评级，目标股价为685美元 [1] - 该研究机构认为公司股票在从1月份的610美元高点回落后，目前正以折价交易，当前交易区间为投资者提供了买入机会 [2] 公司业绩与产品进展 - 公司第二季度营收同比增长21%，达到24.4亿美元 [3] - 增长得益于da Vinci 5外科手术系统进入广泛推广阶段 [3] - 公司有五个变革性产品即将发布，这些发布预计将增强市场对该公司股票的情绪 [3] 公司业务概览 - Intuitive Surgical开发并销售da Vinci机器人辅助外科手术系统，该技术旨在通过增强精度、视野和控制力，使外科医生能够进行微创手术 [4] - 公司的目标是使手术对患者更有效且创伤更小 [4]

Key Takeaways SYK partners with Siemens Healthineers to co-develop a robotic neurovascular system.The collaboration integrates robotics, imaging and SYK devices for faster care.SYK aims to enhance workflows, precision and patient outcomes in neurovascular procedures.Stryker (SYK) recently entered into a strategic partnership with Siemens Healthineers to co-develop a first-of-its-kind robotic system for neurovascular procedures. The collaboration is designed to integrate robotics, imaging and Stryker’s neuro ...

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. DXCM, citing that the company sold the "adulterated" device.Benzinga reached out to DexCom for comments and is yet to hear from them.A surprise FDA inspection found Dexcom made an unauthorized design change to the G7 glucose monitoring device, with internal tests showing worse accuracy across the board.Despite this, the company sold the device, drawing FDA scrutiny. Executives have since departed as patient complaints climbed, rivals ...

We recently published All-Time Rush: 8 of 10 Big Names Hit Fresh Record Highs. Hologic Inc. (NASDAQ:HOLX) is one of the best performers on Wednesday. Shares of Hologic Inc. rallied by 7.69 percent on Wednesday to close at $68.20 as investors repositioned portfolios amid reports that it was again in talks with two investment companies for a potential sale. According to a report by Bloomberg, Hologic Inc. (NASDAQ:HOLX) has received a new acquisition offer from Blackstone Inc. and TPG Inc. after earlier neg ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Inspire Medical Systems, Inc. stands tenth among them. Inspire Medical Systems, Inc. (NYSE:INSP), a leader in minimally invasive devices for obstructive sleep apnea (OSA), reported challenges in the commercial rollout of its new Inspire V system. Delays in onboarding treatment centers and navigating reimbursement processes have slowed full patient adoption, with some patients still using the older Inspire I ...